Sol-Gel Technologies (SLGL) Current Leases (2019 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Current Leases came in at $485000.0 in Q1 2026, up 12.01% year-on-year from $433000.0 in Q1 2025, and down 2.02% on a QoQ basis from $495000.0 in Q4 2025.
Sol-Gel Technologies (SLGL) Current Leases (2019 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 8 years of Current Leases data on file, last reported at $485000.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 12.01% year-over-year to $485000.0 in Q1 2026; TTM through Mar 2026 was $485000.0, a 12.01% increase from a year earlier, with the FY2025 full-year figure at $495000.0, up 15.12% from the prior year.
- Current Leases for Q1 2026 stood at $485000.0, down from $495000.0 in the prior quarter.
- Over the last five years, Current Leases for SLGL reached as high as $766000.0 in Q1 2022 and fell as low as $376000.0 in Q2 2024.
- Historically, Current Leases has averaged $513352.9 across 5 years, with a median of $482000.0 in 2025.
- Across the five-year window, Current Leases plunged 38.23% in 2023 and grew 28.19% in 2025, its largest moves.
- Year by year, Current Leases stood at $718000.0 in 2022, then sank by 37.74% to $447000.0 in 2023, then retreated by 3.8% to $430000.0 in 2024, then gained by 15.12% to $495000.0 in 2025, then decreased by 2.02% to $485000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $485000.0 in Q1 2026, $495000.0 in Q4 2025, and $491000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 485,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 485,000.00 |
| Dec 31, 2025 | 495,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 482,000.00 |
| Mar 31, 2025 | 433,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Sep 30, 2024 | 384,000.00 |
| Jun 30, 2024 | 376,000.00 |
| Mar 31, 2024 | 386,000.00 |
| Dec 31, 2023 | 447,000.00 |
| Sep 30, 2023 | 467,000.00 |
| Jun 30, 2023 | 433,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Dec 31, 2022 | 718,000.00 |
| Sep 30, 2022 | 689,000.00 |
| Jun 30, 2022 | 701,000.00 |
| Mar 31, 2022 | 766,000.00 |
| Dec 31, 2021 | 781,000.00 |
| Sep 30, 2021 | 652,000.00 |
| Jun 30, 2021 | 649,000.00 |